Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prediction of fentanyl plasma and effect-site concentrations in high BMI or low body weight patients
jRCT1021230025Recruiting
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fentanyl in Overweight, obesity and Underweight (4 arms), sponsored by none. Primary endpoints: Model parameters for predicting fentanyl plasma and effect-site concentrations, MDPE (Median Prediction Error) for fentanyl concentration models and 1 more. Started Jan 2024; status: recruiting.
02
Drugs
fentanyl
03
Conditions
OverweightobesityUnderweight
Beyond the preview
Go deeper on jRCT1021230025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1021230025.